Asthma

An inflammatory condition of the airways, asthma typically presents during childhood. It is very common, and affects hundreds of millions of people worldwide. Asthma is often

...


Read more on Asthma

 

 

Latest news articles

Added 5 days ago Drug news

Phase III PALLADIUM data on new inhaled dual combination QMF 149 show significant improvement across key asthma outcomes versus monotherapy.- Novartis

Novartis announced data from the 52-week pivotal Phase III PALLADIUM clinical trial which demonstrated that QMF 149, a once-daily fixed-dose...

Added 1 month ago Drug news

Fevipiprant, ZEAL 1 and 2 phase III trials, did not meet the primary efficacy endpoint of FEV1 improvement in moderate asthmatic patients. Novartis

Novartis reported in its financials for Q3 2019 :Fevipiprant (QAW 039) ZEAL 1 and 2 trials did not meet the...

Added 1 month ago Drug news

Two new options for self-administration of Nucala now approved in Canada for patients with severe eosinophilic asthma.

Nucala (mepolizumab) has been approved in Canada in two new formats – a pre-filled auto-injector and a pre-filled safety syringe...

Search all news articles for Asthma
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Moderate to severe asthma

Moderate to severe asthma

Access the comprehensive Learning Zone for moderate to severe asthma. Containing details about pathophysiology, a complete overview of asthma and daily reports from ERS Congress 2019. 

Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrotic interstitial lung disease that occurs mostly in older adults, is limited to the lungs and often displays a characteristic imaging and histological appearance. Find out how to diagnose IPF and the latest interventions available for patients living with this burden.

Load more

Guidelines

British Guideline on the Management of Asthma

The 2019 update includes a complete revision of the section on monitoring asthma including new information on predicting future risk of asthma attacks, and updates to the sections on pharmacological management of asthma

Added 5 years ago

Asthma: diagnosis, monitoring and chronic asthma management

This guideline covers diagnosing, monitoring and managing asthma in adults, young people and children. It aims to improve the accuracy of diagnosis, help people to control their asthma and reduce the risk of asthma attacks.

Added 1 year ago

Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases

The present guideline was developed on behalf of and financed by the German Society for Allergology and Clinical Immu-nology (Deutsche Gesellschaft für Allergologie und klinische Immunologie, DGAKI)...

Added 2 years ago

Search all guidelines for Asthma
 

Journal articles

Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype.

Objective: We sought to assess the long-term safety, efficacy, and pharmacodynamics of mepolizumab in children aged 6 to 11 years with severe asthma with an eosinophilic phenotype.

Added 14 days ago

Bronchoscopy in severe childhood asthma: Irresponsible or irreplaceable?

For children with severe asthma, guideline‐based management focuses on the escalation of anti‐inflammatory and bronchodilatory medications while addressing comorbid conditions. Bronchoscopy, in this context, has been relegated to...

Added 14 days ago

A potential role of triple therapy for asthma patients.

Areas covered: The pharmacological rationale that explains why it is possible to use triple therapy in asthma and the results of clinical studies that have explored the effects of this therapy in asthmatics is critically examined.

Added 14 days ago

Search all journal articles for Asthma
 

Clinical trials

A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic Fibrosis (SMR3372)

Randomized, double blind, placebo controlled study. The study has two parts:
Dose-finding part, followed by longer term follow-up (6 months)

Added 1 month ago

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller

This is a Phase IIa, randomized, placebo-controlled, double-blind, multicenter, two-arm study to evaluate the efficacy, safety, and pharmacokinetics of MTPS9579A as an add-on therapy in patients with uncontrolled moderate to severe asthma...

Added 1 month ago

Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma (PERSEA)

The purpose of this phase III Study is to demonstrate the efficacy of at least one dose of CHF 6532 on moderate and severe asthma exacerbations rate compared to placebo.

Added 1 month ago

Search all clinical trials for Asthma
 
Georgina Mason

ERS 2018 | Day 5 Highlights

The Asthma Report wraps up from Paris, with our final report from ERS Congress 2018.

 

CME

Respiratory care clinical Q&A November 2015

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0

Management of acute cough in children

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0

Easily missed: Occupational asthma

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
0
Registration required
1
Subscription fee
89
Search all CME for Asthma